stemspantm sfem ii medium (STEMCELL Technologies Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

STEMCELL Technologies Inc stemspantm sfem ii medium
Stemspantm Sfem Ii Medium, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stemspantm+sfem+ii+medium/stemspantm+sfem+ii+medium/pmc12278485-32-4-8
Average 90 stars, based on 1 article reviews

stemspantm sfem ii medium - by Bioz Stars, 2026-09

90/100 stars

Images

Recombinant:

Article Title: A melanoma brain metastasis CTC signature and CTC:B cell clusters associate with secondary liver metastasis: a melanoma brain-liver metastasis axis
Article Snippet: The cells were then washed twice with Stemline® II Hematopoietic Stem Cell Expansion Medium (S0192, Sigma-Aldrich). .. The donor cell pellet was resuspending in 1 mL of StemSpanTM SFEM II medium (09605, STEMCell Technologies Inc.) supplemented with 0.1 μg/ml Human Recombinant SCF (78062.1, STEMCell Technologies Inc.) prior to cell counting. ..

Cell Counting:

Cell Culture:

Article Title: Innovative evaluation of selinexor and JQ1 synergy in leukemia therapy via C-MYC inhibition.
Article Snippet: Mononuclear cells were separated from BM samples by LymphoprepTM (STEMCELL Technologies, Canada) using density gradient certification. .. The mononuclear cells were cultured in StemSpanTM SFEM II medium (STEMCELL Technologies, Canada) supplemented with 10 ng/mL rh-SCF, 10 ng/mL human IL3, 10 ng/mL human IL6 (all cytokines were purchased from R&D Systems, USA). ..

Article Title: NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis
Article Snippet: Purity (> 90%) was confirmed by flow cytometry using anti-human CD34 antibody (BioLegend, Cat# 378604). .. Cells were cultured in StemSpanTM SFEM II medium (Stemcell Technologies) supplemented with SCF (100 ng/mL), Flt3-L (100 ng/mL), and TPO (50 ng/mL) at 37 °C with 5% CO2. ..

Article Title: Overcoming immunotherapy resistance in colorectal cancer through nano-selenium probiotic complexes and IL-32 modulation.
Article Snippet: Background and objective: Colorectal cancer (CRC) is a major global health burden, with immunotherapy often limited by immune tolerance and resistance.. This study introduces an innovative approach using Selenium Nanoparticles-Loaded Extracellular Vesicles combined with Interleukin-32 and Engineered Probiotic Escherichia coli Nissle 1917 (SeNVs@NE-IL32-EcN) to enhance CD8 T cell-mediated immune responses and overcome immunotherapy resistance.. Methods: Single-cell RNA sequencing (scRNA-seq) and transcriptomic analyses were performed to identify key immune cells and regulators involved in CRC immunotherapy resistance, focusing on CD8 T cells and the regulatory factor IL32.

other:

Article Title: Sensitive Transcriptomics and Genotyping reveals function of genetic variants in immunity
Article Snippet: The cells were seeded in 6-well plates at a density of 1×10 /ml in StemSpanTM SFEM II medium (stemCell Technologies, 02690) with 1% L-glutamine (Thermo Fisher Scientific, 25-030-081) and 1% penicillin/streptomycin (Life Technologies, 10378016) and also cytokine supplements at different stages following differentiation protocols from previous reports .

Review